Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-chp) on OutcomesGilles Salles,Franck Morschhauser,Laurie H. Sehn,Alex F. Herrera,Jonathan W. Friedberg,Marek Trněný,Georg Lenz,Jeff P. Sharman,Charles Herbaux,John M. Burke,Matthew Matasar,Graham P. Collins,Yuqin Song,Antonio Pinto,Shinya Rai,Koji Izutsu,Calvin Lee,Saibah Chohan, Matthew Sugidono,Yanwen Jiang,Connie Lee Batlevi,Mark Yan,Jamie Hirata,Hervé Tilly,Christopher R. FlowersBlood（2024）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
